Regular sleep predicts risk
In UK Biobank, sleep regularity predicted mortality risk more strongly than sleep duration.
Windred DP et al. Sleep, 2024
Hello from poster F170. Thank you for scanning it. Here is how the method works, and how to reach us.
Actogram is a circadian science technology company. We turn ordinary step counts into measures of the body's daily rhythm and bridge research and industry: tools and partnership for researchers, and an SDK that brings the rhythm into wellness apps and devices.
Meet us at Sleep Europe 2026, Maastricht: poster F170, Friday 23 October, 12:30–13:30
Why rhythm
Smartphones track the day from midnight to midnight. The body doesn't: its day moves with work, travel and late nights, and research shows that how regular it stays matters for health.
In UK Biobank, sleep regularity predicted mortality risk more strongly than sleep duration.
Windred DP et al. Sleep, 2024
A National Sleep Foundation panel concluded that regular sleep–wake timing is important for health.
Sletten TL et al. Sleep Health, 2023
Body clocks differ widely between people, and work schedules often pull sleep away from them.
Roenneberg T et al. J Biol Rhythms, 2003
Actogram superpower
Extend your circadian-data pipeline beyond clock-based annotation. Turn continuous or retrospective human activity data into biologically meaningful days, nights and rhythm patterns, without assuming a conventional 24-hour schedule.
Requires no clock-time anchors. Naturally follows the rhythm across jet lag, time-zone shifts and daylight saving time changes.
Identifies subjective days and nights even under shift work, irregular schedules and disrupted sleep–wake cycles.
Tested against ground truth and health-related labels in large population cohorts.
Works from step counts alone, enabling broad cross-platform and legacy-data compatibility and extending circadian analysis further back into individual and cohort history.
How it works
Rhythmoscope reads each person's rhythm from minute-by-minute steps from a smartphone or watch. The same algorithm, the Actogram core, is small enough for ultra-low-power chips.
Steps from a smartphone or watch, minute by minute. No heart rate, no sleep stages.
No steps looks like rest, asleep or watch off. Over 12 hours of “rest” flags the day as unreliable.
Days and nights are found from the steps, not cut at 00:00: when each day starts, peaks and winds down.
Within a day: does activity hold up until evening? Day to day: are wake-up and bedtimes steady?
Ongoing research. Stability can be estimated from ordinary step counts. Formal validation is next: we are looking for sleep labs to test it against DLMO (the lab's melatonin marker of the body clock) and actigraphy.
Limits. Rest is inferred from steps, not measured sleep. A watch left on the table looks like rest.
Today: research use only, not a medical device.
For research groups
Invite us into your grant application as the industrial partner, and your results get a road beyond the paper: large cohorts, a smartphone app and SDK, and low-power silicon.
Academic partners
Academic partners, plus an industrial partner
A plan for later use
A technology track already under way: app, SDK and silicon
Results end in the paper
Results can move on: large cohorts, an app, a chip
Funding for selected studies
Pilot study or analysis of existing dataup to USD 50,000
Collaborative or clinical study, full termup to USD 1 million
Sleep labs: help us test it against DLMO and actigraphy. A validation pilot can be funded up to USD 50,000.
Contact usProducts
One way of reading the rhythm, in three tools. Try the research assistant in your browser today, and see the SDK at work in our iPhone demo.
Open to try
Ask research questions in plain language about NHANES, a US health survey with activity data from about 30,000 people.
Research preview
Months of rest and activity, day by day: each person's rhythm and its stability at a glance, and a report in one click.
Demo in testing
Rhythm features for wellness apps and connected devices, such as a smart mattress: indicators, timely nudges and progress.
Actogram SDK
For wellness apps and connected devices. The SDK turns the steps your product already collects into features that follow each person's day and bring people back.
Steps in
Live stepsfrom a phone, watch or band
Past daysfrom Apple Health, with the user's permission
Actogram SDK, inside your app
Tuned to each person's own day
In your product
New daily featuresguidance that follows each person's day
A reason to come backprogress people want to keep
And, if you wish, research for your brand. With your users' consent, we compare their rhythm before and after they start using your product, and you get a research report under your brand.
The SDK is in development, and our iPhone app shows it at work. The app is a demo, not a commercial product.
Talk to us about the SDKResearch assistant, in your browser
Biobank MCP, our research app on Hugging Face. Answers use the survey's weights, and each number comes with the call that repeats it.
Benchmarked against NCHS: tests reproduce 56 published estimates. See the checks
Open on Hugging FaceSDK demo, for iPhone
Biomatic, our demo app, reads steps from Apple Health and shows the day's rhythm hour by hour. A demo of the SDK, not a commercial product.
iPhone only, iOS 17 or later. Free, through Apple's TestFlight.
Join the waitlistThe public beta opens soon. Join the waitlist now, and we will e-mail you the invite as soon as it opens.
It installs through TestFlight, Apple's free app for trying apps before they reach the App Store.
Pipeline
Two programmes grow from one core. Each climbs the technology readiness scale, from a lab idea (TRL 1) to a product in everyday use (TRL 9), in four stages.
Actogram coreone shared algorithm, two tracks
Science trackSleep–wake stability
Population researchactivity of about 30,000 people (NHANES)Stage 1: Research, TRL 1–3
We are hereiPhone app in testingApple Health steps, hourly activity goals; more testers nextStage 2: Prototype, TRL 4–5
Human studybehavioural intervention, target 10,000 peopleStage 3: Validation, TRL 6–7
Telemedicine and appsif validated, built into partner platformsStage 4: Scale-up, TRL 8–9
Technology trackUltra-low-power chip
Reference algorithmthe master copy, on a computerStage 1: Research, TRL 1–3
We are hereWatch prototyperunning on a test watchStage 2: Prototype, TRL 4–5
Low-power prototypetwo years battery life (10 µA)Stage 2: Prototype, TRL 4–5
Chip designthe same results as the reference algorithmStage 3: Validation, TRL 6–7
Licensingfor watch and chip makersStage 4: Scale-up, TRL 8–9
Science trackDigital sleep–wake programme
Technology trackCircadian core in a chip
Team
A small team of scientists and engineers, registered in London as Actogram Ltd.
CEO
Serial entrepreneur: more than 25 years of founding and growing companies in telecommunications, consumer electronics and biotechnology, with several successful exits.
Chief Data Scientist
Researcher and software lead: more than twenty years in bioinformatics and health technology, more than 20 papers and 2 patents, including work on biological age and resilience from wearable data.
Questions
We read the body's daily rhythm from ordinary step counts and carry it from research into products: tools and industrial partnership for researchers, and an SDK that brings the rhythm into wellness apps and devices.
Not today. Our tools are for research and wellness use and do not diagnose, treat or prevent any condition. If validated, the science track aims at a regulated digital health product, and the technology track at the low-power chip for such devices.
Only minute-level step counts from a smartphone or watch: no heart rate, no sleep stages. A watch left on the table looks like rest, so a simple check flags days with implausibly long rest.
Not yet. Stability can be estimated from ordinary step counts; formal validation is the next step, and we are looking for sleep labs to test it against DLMO and actigraphy.
Invite us into your grant application as the industrial partner. We add a route from your results to products: large cohorts, an app and SDK, and low-power silicon. We also provide data and analysis tools, and fund selected studies: up to USD 50,000 for a pilot or analysis of existing data, and up to USD 1 million for a collaborative or clinical study.
Yes, that is what the Actogram SDK is for. It works from the steps your product already has, and our iPhone demo shows it at work. Write to us and we will plan it together.
DLMO is the time melatonin starts to rise in dim light, the lab's standard marker of the body clock. Actigraphy is movement recording with a wrist device. NHANES is a large US national health survey; part of it recorded a week of activity for about 30,000 people.
Actogram Ltd is registered in London, United Kingdom.
Contact
Now looking for: sleep labs for validation, and app and device makers to try the SDK.
Maastricht, 20–23 October. Poster F170: Friday 23 October, 12:30–13:30.
Actogram Ltd, 71–75 Shelton Street, Covent Garden, London WC2H 9JQ, United Kingdom